Across TCGA pan-cancer cohorts, H1-10-AS1 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated H1-10-AS1 data layer compared with 21 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher H1-10-AS1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated H1-10-AS1 expression acts as an unfavorable survival marker.
UCEC are the cancer types where H1-10-AS1 Mutation most reproducibly stratifies survival.